Publications by authors named "John Panetta"

Claim this Profile
A
Age-adjusted dosing of fludarabine for lymphodepletion in CAR T-cell therapy: a clinical trial simulation study.
John C Panetta, Aimee C Talleur, Swati Naik, Stephen Gottschalk, Markos Leggas

Blood Adv· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Changes in asparaginase exposure and toxicity profiles in obese pediatric acute lymphoblastic leukemia patients.
John C Panetta, Emily Ashcraft, Sima Jeha, Ching-Hon Pui, Hiroto Inaba

Haematologica· August 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Desensitization to calaspargase pegol appears to be less successful than pegaspargase.
Milre Matherne, John C Panetta, Jaclyn Hopp, Hiroto Inaba, Ching-Hon Pui

Blood Adv· April 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
Ustekinumab Drug Clearance Is Better Associated with Disease Control than Serum Trough Concentrations in a Prospective Cohort of Inflammatory Bowel Disease.
Andres J Yarur, Thierry Dervieux, Ryan Ungaro, Elizabeth A Spencer, Alexandra Bruss, John C Panetta

Pharmaceutics· February 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Population Pharmacokinetic and Pharmacodynamic Study of Palbociclib in Children and Young Adults with Recurrent, Progressive, or Refractory Brain Tumors.
John C Panetta, Nicholas S Selvo, David Van Mater, Clinton F Stewart

Pharmaceutics· November 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Ommaya reservoir use in pediatric ALL and NHL: a review at St. Jude Children's Research Hospital.
Alyssa Gaietto, John C Panetta, Jennifer L Pauley, Mary V Relling, Raul Ribeiro

Cancer Chemother Pharmacol· June 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Forecasted infliximab concentrations during induction predict time to remission and sustained disease control of inflammatory bowel disease.
Severine Vermeire, Marla C Dubinsky, Shervin Rabizadeh, John C Panetta, Elisabeth A Spencer

Clin Res Hepatol Gastroenterol· June 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Adalimumab Clearance, Rather Than Trough Level, May Have Greatest Relevance to Crohn's Disease Therapeutic Outcomes Assessed Clinically and Endoscopically.
Emily K Wright, Maria Chaparro, Paolo Gionchetti, Amy L Hamilton, Julien Schulberg, John C Panetta

J Crohns Colitis· February 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Treosulfan Exposure Predicts Thalassemia-Free Survival in Patients with Beta Thalassemia Major Undergoing Allogeneic Hematopoietic Cell Transplantation.
Aswin Anand Pai, Ezhilpavai Mohanan, John C Panetta, Uday P Kulkarni, Raveen Stephen Stallon Illangeswaran

Clin Pharmacol Ther· January 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The Combination of Predictive Factors of Pharmacokinetic Origin Associates with Enhanced Disease Control during Treatment of Pediatric Crohn's Disease with Infliximab.
Marla C Dubinsky, Shervin Rabizadeh, John C Panetta, Elizabeth A Spencer, Annelie Everts-van der Wind

Pharmaceutics· September 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pharmacokinetics and safety of bendamustine in the BEABOVP regimen for the treatment of pediatric patients with Hodgkin lymphoma.
Katelyn N Purvis, Hope D Swanson, Kumar Kulldeep Niloy, Yiwang Zhou, John C Panetta

Cancer Chemother Pharmacol· July 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Preclinical pharmacokinetic and pharmacodynamic evaluation of dasatinib and ponatinib for the treatment of T-cell acute lymphoblastic leukemia.
Satoshi Yoshimura, John C Panetta, Jianzhong Hu, Lie Li, Yoshihiro Gocho

Leukemia· June 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Preclinical evaluation of proteolytic targeting of LCK as a therapeutic approach in T cell acute lymphoblastic leukemia.
Jianzhong Hu, Jamie Jarusiewicz, Guoqing Du, Gisele Nishiguchi, Satoshi Yoshimura, John C Panetta

Sci Transl Med· August 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Preclinical and Pilot Study of Type I FLT3 Tyrosine Kinase Inhibitor, Crenolanib, with Sorafenib in Acute Myeloid Leukemia and FLT3-Internal Tandem Duplication.
Hiroto Inaba, Jolieke G van Oosterwijk, John C Panetta, Lie Li, Daelynn R Buelow

Clin Cancer Res· June 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Combining SJ733, an oral ATP4 inhibitor of Plasmodium falciparum, with the pharmacokinetic enhancer cobicistat: An innovative approach in antimalarial drug development.
Aditya H Gaur, John C Panetta, Amber M Smith, Ronald H Dallas, Burgess B Freeman

EBioMedicine· June 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Model Informed Precision Dosing Tool Forecasts Trough Infliximab and Associates with Disease Status and Tumor Necrosis Factor-Alpha Levels of Inflammatory Bowel Diseases.
Christian Primas, Walter Reinisch, John C Panetta, Alexander Eser, Diane R Mould

J Clin Med· June 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Changes in body mass index, weight, and height in children with acute myeloid leukemia and the associations with outcome.
Mayuko Iijima, Melanie Stall, Lei Wang, John C Panetta, Brandon M Triplett

Blood Adv· May 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Comprehensive analysis of dose intensity of acute lymphoblastic leukemia chemotherapy.
Seth E Karol, Deqing Pei, Colton A Smith, Yiwei Liu, Wenjian Yang, John C Panetta

Haematologica· February 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
P010 Precision Dosing Tool Forecasts Trough Infliximab and Associates With Disease Status in Inflammatory Bowel Diseases.
Thierry Dervieux, Christian Primas, John Panetta, Diane Mould, Alexander Eser

Am J Gastroenterol· December 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pharmacokinetically guided dosing of oral sorafenib in pediatric hepatocellular carcinoma: A simulation study.
John C Panetta, Olivia Campagne, Jessica Gartrell, Wayne Furman, Clinton F Stewart

Clin Transl Sci· November 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pharmacodynamics of cerebrospinal fluid asparagine after asparaginase.
John C Panetta, Yiwei Liu, Teodoro Bottiglieri, Erland Arning, Cheng Cheng

Cancer Chemother Pharmacol· October 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Association between obesity and neurocognitive function in survivors of childhood acute lymphoblastic leukemia treated only with chemotherapy.
Mayuko Iijima, Wei Liu, John C Panetta, Melissa M Hudson, Ching-Hon Pui

Cancer· September 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Identification of small molecules that mitigate vincristine-induced neurotoxicity while sensitizing leukemia cells to vincristine.
Barthelemy Diouf, Claudia Wing, John C Panetta, Donnie Eddins, Wenwei Lin

Clin Transl Sci· July 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Phase 1 study of bendamustine in combination with clofarabine, etoposide, and dexamethasone in pediatric patients with relapsed or refractory hematologic malignancies.
Sima Jeha, Kristine R Crews, Deqing Pei, Melissa Peyton, John C Panetta

Cancer· June 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Limited sampling strategies for accurate determination of extended half-life factor VIII pharmacokinetics in severe haemophilia A patients.
Alanna McEneny-King, Pierre Chelle, Margaret H Goggans, Patricia J Barker, Timothy W Jacobs, John C Panetta

Haemophilia· May 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis